Legend Biotech Corp ADR (LEGN): Next-Year EPS Estimate 1122.84%
As of 2026-06-18, Legend Biotech Corp ADR (LEGN) has a next-year EPS growth estimate of 1122.84%. Featured in 3 EPS revision reports, most recently on 2026-04-23.
On 2026-06-18, analyst consensus for LEGN's next-year EPS growth shifted from 932.53% to 1122.84% — a positive change of 190.31 percentage points. Current-year growth is projected at 109.06%.
Current Snapshot
- Sector
- Healthcare
- Industry
- Biotechnology
- EPS growth next year
- 1122.84%
- EPS growth this year
- 109.06%
- EPS next quarter (est)
- $0.08
- Last price
- $27.93
EPS Revision History
| Date | EPS Next Y | EPS This Y | Next Q (est) | Price |
|---|---|---|---|---|
| 2026-06-18 | 1122.84% | 109.06% | $0.08 | $27.93 |
| 2026-06-17 | 932.53% | 110.88% | $0.08 | $33.52 |
| 2026-06-16 | 909.25% | 111.26% | $0.08 | $33.38 |
| 2026-06-15 | 909.25% | 111.26% | $0.08 | $35.48 |
| 2026-06-14 | 909.25% | 111.26% | $0.08 | $35.87 |
| 2026-06-11 | 909.25% | 111.26% | $0.08 | $36.28 |
| 2026-06-10 | 909.25% | 111.26% | $0.08 | $34.86 |
| 2026-06-09 | 909.25% | 111.26% | $0.08 | $33.49 |
| 2026-06-08 | 909.25% | 111.26% | $0.08 | $31.52 |
| 2026-06-07 | 909.25% | 111.26% | $0.08 | $32.62 |
| 2026-06-04 | 909.25% | 111.26% | $0.08 | $34.20 |
| 2026-06-03 | 909.25% | 111.26% | $0.08 | $35.98 |
| 2026-06-02 | 813.80% | 112.38% | $0.07 | $36.28 |
| 2026-06-01 | 813.80% | 112.38% | $0.07 | $25.51 |
| 2026-05-31 | 950.63% | 110.63% | $0.06 | $27.16 |
| 2026-05-28 | 950.63% | 110.63% | $0.06 | $28.26 |
| 2026-05-27 | 950.63% | 110.63% | $0.06 | $28.50 |
| 2026-05-26 | 950.63% | 110.63% | $0.06 | $29.53 |
| 2026-05-25 | 950.63% | 110.63% | $0.06 | $29.37 |
| 2026-05-24 | 950.63% | 110.63% | $0.06 | $29.37 |
| 2026-05-21 | 950.63% | 110.63% | $0.06 | $27.99 |
| 2026-05-20 | 950.63% | 110.63% | $0.06 | $28.12 |
| 2026-05-19 | 950.63% | 110.63% | $0.06 | $26.94 |
| 2026-05-18 | 950.63% | 110.63% | $0.06 | $26.98 |
| 2026-05-17 | 905.32% | 111.07% | $0.05 | $27.55 |
| 2026-05-14 | 830.77% | 112.17% | $0.05 | $28.60 |
| 2026-05-13 | 830.77% | 112.17% | $0.05 | $28.90 |
| 2026-05-12 | 375.96% | 125.33% | $0.06 | $28.26 |
| 2026-05-11 | 307.25% | 129.86% | $0.01 | $25.58 |
| 2026-05-10 | 307.25% | 129.86% | $0.01 | $28.12 |
Reports Featuring LEGN
Recent News
Screen Performance
Aggregate stats across all 1795 tickers our top-EPS-revision screen has flagged over the past 78 days.
- Median return since detection
- +3.6%
- % of tickers in the green
- 58%
- Median return on winners
- +19.9%
- Large revisions captured
- 842
Past detection performance reflects the price change between when a ticker first entered our screen and the most recent observation. Not a forward-looking forecast.
Frequently Asked Questions
What is Legend Biotech Corp ADR's next-year EPS growth estimate?▾
As of 2026-06-18, Legend Biotech Corp ADR (LEGN) has a next-year EPS growth estimate of 1122.84%, based on analyst consensus.
When was the latest EPS estimate revision for LEGN?▾
The most recent revision occurred on 2026-06-18, when analysts adjusted the next-year EPS growth estimate from 932.53% to 1122.84%.
What sector and industry does Legend Biotech Corp ADR belong to?▾
Legend Biotech Corp ADR operates in the Healthcare sector, specifically the Biotechnology industry.
How often is this EPS estimate data updated?▾
EPS revision data is refreshed daily from analyst consensus estimates. LEGN appears on this page because it was flagged by our daily top-EPS-revision-performer screen.
EPS revision data sourced from analyst consensus estimates, refreshed daily. Legend Biotech Corp ADR (LEGN) appears here because it was detected by our daily top-EPS-revision-performer screen.
← All reports